The Breast Center at the Moores UCSD Cancer Center has received accreditation from the National Accreditation Program of Breast Centers (NAPBC), a program administered by the American College of Surgeons. The Breast Center at the Moores UCSD Cancer Center is the first hospital-based program in California to receive this accreditation.

According to the NAPBC, this recognition – which is for three years and is considered “full accreditation” – is given only to those centers that “provide the highest level of quality breast care and that undergo a rigorous evaluation process and review of their performance.”

The NAPBC review includes such areas as leadership, clinical management, research, community outreach, professional education and quality improvement. In all, the Cancer Center’s Breast Center met all 27 standards set by the NAPBC.

“The accreditation from such an important organization only underscores the high level of expertise and commitment from our doctors, nurses and staff at the Moores Cancer Center,” said Anne Wallace, MD, professor of clinical surgery at the UC San Diego School of Medicine and Director of the Breast Center at the Moores UCSD Cancer Center. “All of us share in this recognition.”

“It’s an extraordinary honor to be recognized by a national medical organization for our exceptional work and continued dedication to our patients,” said Barbara Parker, MD, professor of clinical medicine at the UC San Diego School of Medicine and medical director of oncology services at the Moores UCSD Cancer Center.

The NAPBC is a consortium of professional organizations dedicated to improving quality of care and monitoring outcomes of patients with breast disease and breast cancer.

The UCSD Moores Cancer Center is one of the nation’s 40 National Cancer Institute-designated Comprehensive Cancer Centers, combining research, clinical care and community outreach to advance the prevention, treatment and cure of cancer.

Related Specialties

Media Contact

Related News

Researchers at the University of California, San Diego School of Medicine have demonstrated a direct connection between two signaling proteins and liver fibrosis, a scarring process underlying chronic ...

Researchers at University of California, San Diego School of Medicine have established the safety and dosing of a new drug for treating blood cancers. The findings are published online July 27 in The ...

UC San Diego Health, with the University of California, San Diego School of Medicine, has entered into a multi-year affiliation agreement with La Jolla Institute for Allergy and Immunology (LJI) desig ...

On Friday, July 24, Superior Court Judge Judith F. Hayes found in favor of the University of California Regents’ request for a preliminary injunction to restore rightful custody and control of Alzheim ...